Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketalar vs Dexmedetomidine for Remifentanil-induced Hyperalgesia
NCT06473896Recruiting
- Sponsor
- Shamir Medical Center
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in opioid-induced hyperalgesia (OIH) comparing Ketalar with Dexmedetomidine (2 arms). Primary endpoints: Pain Level and Pain killer consumption. Started Apr 2024; status: recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on NCT06473896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06473896.